ICON Total Liabilities 2010-2025 | ICLR

ICON total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • ICON total liabilities for the quarter ending March 31, 2025 were $7.222B, a 5.17% decline year-over-year.
  • ICON total liabilities for 2024 were $7.355B, a 5.09% decline from 2023.
  • ICON total liabilities for 2023 were $7.749B, a 10.8% decline from 2022.
  • ICON total liabilities for 2022 were $8.687B, a 6.79% decline from 2021.
ICON Annual Total Liabilities
(Millions of US $)
2024 $7,355
2023 $7,749
2022 $8,687
2021 $9,320
2020 $1,585
2019 $1,250
2018 $1,000
2017 $956
2016 $881
2015 $954
2014 $579
2013 $532
2012 $448
2011 $354
2010 $280
2009 $336
ICON Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $7,222
2024-12-31 $7,355
2024-09-30 $7,437
2024-06-30 $7,384
2024-03-31 $7,616
2023-12-31 $7,749
2023-09-30 $8,072
2023-06-30 $8,311
2023-03-31 $8,633
2022-12-31 $8,687
2022-09-30 $8,887
2022-06-30 $8,890
2022-03-31 $9,094
2021-12-31 $9,320
2021-09-30 $9,686
2021-06-30 $1,557
2021-03-31 $1,532
2020-12-31 $1,585
2020-09-30 $1,354
2020-06-30 $1,280
2020-03-31 $1,327
2019-12-31 $1,250
2019-09-30 $1,208
2019-06-30 $1,190
2019-03-31 $1,185
2018-12-31 $1,000
2018-09-30 $991
2018-06-30 $936
2018-03-31 $1,014
2017-12-31 $956
2017-09-30 $926
2017-06-30 $875
2017-03-31 $911
2016-12-31 $881
2016-09-30 $909
2016-06-30 $840
2016-03-31 $952
2015-12-31 $954
2015-09-30 $950
2015-06-30 $614
2015-03-31 $606
2014-12-31 $579
2014-09-30 $562
2014-06-30 $527
2014-03-31 $524
2013-12-31 $532
2013-09-30 $508
2013-06-30 $491
2013-03-31 $463
2012-12-31 $448
2012-09-30 $416
2012-06-30 $421
2012-03-31 $424
2011-12-31 $354
2011-09-30 $348
2011-06-30 $302
2011-03-31 $321
2010-12-31 $280
2010-09-30 $291
2010-06-30 $284
2010-03-31 $312
2009-12-31 $336
2009-09-30 $381
2009-06-30 $390
2009-03-31 $376
Sector Industry Market Cap Revenue
Medical Medical Services $12.241B $8.282B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.621B 26.94
CVS Health (CVS) United States $84.680B 10.52
Elevance Health (ELV) United States $78.955B 10.19
Cencora (COR) United States $57.765B 20.10
DiDi Global (DIDIY) China $23.297B 24.75
Natera (NTRA) United States $21.640B 0.00
Labcorp Holdings (LH) United States $21.549B 17.48
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.690B 0.00
Solventum (SOLV) United States $12.990B 13.75
CochLear (CHEOY) Australia $12.847B 0.00
Revvity (RVTY) United States $11.865B 20.42
Viatris (VTRS) United States $10.868B 3.73
Avantor (AVTR) United States $9.370B 13.61
Medpace Holdings (MEDP) United States $9.269B 24.62
HealthEquity (HQY) United States $8.917B 39.06
Sonic Healthcare (SKHHY) Australia $8.417B 0.00
Charles River Laboratories (CRL) United States $7.779B 15.24
Caris Life Sciences,�Inc (CAI) United States $6.688B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.952B 29.17
BrightSpring Health Services (BTSG) United States $3.769B 34.58
Sotera Health (SHC) United States $3.290B 18.69
Surgery Partners (SGRY) United States $2.853B 37.10
Alignment Healthcare (ALHC) United States $2.712B 0.00
Concentras Parent (CON) United States $2.615B 15.11
Organon (OGN) United States $2.587B 2.75
GeneDx Holdings (WGS) United States $2.432B 93.65
Progyny (PGNY) United States $2.080B 45.79
PACS (PACS) United States $1.972B 0.00
Ardent Health (ARDT) United States $1.970B 8.40
Premier (PINC) United States $1.805B 13.70
GoodRx Holdings (GDRX) United States $1.729B 34.57
Teladoc Health (TDOC) United States $1.493B 0.00
Establishment Labs Holdings (ESTA) $1.271B 0.00
Pediatrix Medical (MD) United States $1.159B 8.82
CareDx (CDNA) United States $1.072B 16.74
Agilon Health (AGL) United States $0.989B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
AMN Healthcare Services Inc (AMN) United States $0.846B 7.92
Nutex Health (NUTX) United States $0.766B 11.59
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.610B 4.11
InnovAge Holding (INNV) United States $0.574B 0.00
LifeMD (LFMD) United States $0.544B 0.00
SBC Medicals (SBC) United States $0.504B 0.00
Sonida Senior Living (SNDA) United States $0.468B 0.00
Auna S.A (AUNA) Luxembourg $0.465B 10.47
Omada Health (OMDA) $0.450B 0.00
So-Young (SY) China $0.423B 0.00
Enhabit (EHAB) United States $0.370B 30.42
Performant Healthcare (PHLT) United States $0.333B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.324B 0.00
Beauty Health (SKIN) United States $0.265B 0.00
Oncology Institute (TOI) United States $0.223B 0.00
DocGo (DCGO) United States $0.158B 25.83
Pheton Holdings (PTHL) China $0.128B 0.00
Sera Prognostics (SERA) United States $0.102B 0.00
KindlyMD (NAKA) United States $0.078B 0.00
IceCure Medical (ICCM) Israel $0.067B 0.00
Ascend Wellness Holdings (AAWH) United States $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
ModivCare (MODV) United States $0.055B 0.00
Biodesix (BDSX) United States $0.043B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
Basel Medical Group (BMGL) Singapore $0.034B 0.00
OSR Holdings (OSRH) United States $0.026B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00